{
  "docId": "019de075-adb8-762c-8a34-68ae2626b554",
  "docSlug": "3a94cd37bbc178d56e25705cc2452800",
  "documentTitle": "Legend Biotech | Results Presentation Deck | 16 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 16,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The chart shows a bridge from 114M to 145M, with a 27M increase in R&D and a 4M increase in SG&A (net of S&D decrease).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-adb8-762c-8a34-68ae2626b554/12",
  "deckHref": "/decks/019de075-adb8-762c-8a34-68ae2626b554",
  "deckJsonHref": "/decks/019de075-adb8-762c-8a34-68ae2626b554.json",
  "deckAnchorHref": "/decks/019de075-adb8-762c-8a34-68ae2626b554#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.43,
        "x": 0.107,
        "y": 0.225
      },
      "kind": "chart",
      "text": "Operating Expenses ($MM)",
      "attrs": null,
      "subkind": "waterfall-bridge",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e3b3d28-c335-4f29-8d00-04fed6beb775",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.38,
        "x": 0.57,
        "y": 0.23
      },
      "kind": "list",
      "text": "2Q 2023 Operating Expenses Growth of 27% versus 2Q 2022. The increases of $27.0 million in R&D expenses was primarily due to: Continuous research and development activities in cilta-cel... An increase in research and development activities for other pipeline items...",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd196108-fb35-4bdc-89b3-01c283102069",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.565,
        "x": 0.107,
        "y": 0.107
      },
      "kind": "title",
      "text": "Focused Investments in Pipeline and Development",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7cb1cb31-8b07-4a30-83a0-62f98bd86e1d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall / value bridge",
      "slug": "waterfall-bridge",
      "agent": null,
      "layer": "slide",
      "matchId": "57015d80-971a-48a0-a858-f91c44c619cf",
      "evidence": "chart/waterfall-bridge: Operating Expenses ($MM)",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "waterfall-bridge",
      "slug": null,
      "matchId": "264f9bb6-0317-4942-9adb-49076c13ef6b",
      "evidence": "The chart visualizes the components of change between two values.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 12,
      "from": 8,
      "beatId": "dcee9c50-004c-4bd0-a189-7451c151e46d",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Key Performance Indicators Overview",
      "beatSlug": null,
      "evidence": "The CARVYKTI uptake, pipeline, and financial highlights are presented, showcasing the company's progress.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}